Stanford V regimen: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}}Stanford V; Stanford V Regimen; Stanford V regimen ==Overview== {{PAGENAME}} refers to a chemotherapy regimen consisting of ..." |
No edit summary |
||
Line 4: | Line 4: | ||
{{SK}}Stanford V; Stanford V Regimen; Stanford V regimen | {{SK}}Stanford V; Stanford V Regimen; Stanford V regimen | ||
==Overview== | ==Overview== | ||
Line 11: | Line 10: | ||
==Regimen== | ==Regimen== | ||
{{chemo|x|Mechlorethamine}} | {{chemo|x|Mechlorethamine}} | ||
{{chemo|x|Doxorubicin hydrochloride}} | {{chemo|x|Doxorubicin hydrochloride}} | ||
{{chemo|x|Vinblastine}} | {{chemo|x|Vinblastine}} | ||
{{chemo|x|Vincristine}} | {{chemo|x|Vincristine}} | ||
Line 22: | Line 24: | ||
==Indications== | ==Indications== | ||
*[[Hodgkin lymphoma]]<ref name="pmid19759185">{{cite journal| author=Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A et al.| title=Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience. | journal=Ann Oncol | year= 2010 | volume= 21 | issue= 3 | pages= 574-81 | pmid=19759185 | doi=10.1093/annonc/mdp337 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19759185 }} </ref> | *[[Hodgkin lymphoma]]<ref name="pmid19759185">{{cite journal| author=Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A et al.| title=Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience. | journal=Ann Oncol | year= 2010 | volume= 21 | issue= 3 | pages= 574-81 | pmid=19759185 | doi=10.1093/annonc/mdp337 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19759185 }} </ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Chemotherapy regimens]] | [[Category:Chemotherapy regimens]] |
Revision as of 18:10, 30 March 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:Stanford V; Stanford V Regimen; Stanford V regimen
Overview
Stanford V regimen refers to a chemotherapy regimen consisting of mechlorethamine, doxorubicin hydrochloride, vinblastine, vincristine, bleomycin, etoposide and prednisone, administered on a compressed schedule and used in the treatment of Hodgkin lymphoma; it may be followed by consolidative radiation therapy.[1][2]
Regimen
xMechlorethamine
xDoxorubicin hydrochloride
xVinblastine
xVincristine
xBleomycin
xEtoposide
xPrednisone
Indications
References
- ↑ 1.0 1.1 Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A; et al. (2010). "Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience". Ann Oncol. 21 (3): 574–81. doi:10.1093/annonc/mdp337. PMID 19759185.
- ↑ "NCI Thesaurus".